These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2142219)

  • 1. Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters.
    Smits GJ; McGraw DE; Trapani AJ; Blaine EB
    J Pharmacol Exp Ther; 1990 Jul; 254(1):176-9. PubMed ID: 2142219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
    Trapani AJ; Beil ME; Coté DT; de Lombaert S; Erion MD; Gerlock TE; Ghai RD; Hopkins MF; Peppard JV; Webb RL
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
    Trippodo NC; Fox M; Natarajan V; Panchal BC; Dorso CR; Asaad MM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):108-16. PubMed ID: 8229737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
    Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE; Ghai RD; Trapani AJ; Odorico LM; Dardik BN; De Lombaert S; Lappe RW; Fink CA
    J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
    Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F
    J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats. Effects of neutral endopeptidase inhibition.
    Hirata Y; Matsuoka H; Hayakawa H; Sugimoto T; Suzuki E; Sugimoto T; Kangawa K; Matsuo H
    Hypertension; 1991 Jun; 17(6 Pt 2):1025-32. PubMed ID: 1828456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
    Koepke JP; Tyler LD; Trapani AJ; Bovy PR; Spear KL; Olins GM; Blaine EH
    J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides.
    Tamura N; Ogawa Y; Itoh H; Arai H; Suga S; Nakagawa O; Komatsu Y; Kishimoto I; Takaya K; Yoshimasa T
    J Clin Invest; 1994 Sep; 94(3):1059-68. PubMed ID: 8083346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis.
    Sansoè G; Aragno M; Mastrocola R; Cutrin JC; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1337-43. PubMed ID: 16449355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
    Pesonen A; Leppäluoto J; Ruskoaho H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats.
    Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.